Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices 2465 

departures from Tier 1 information in 

the certified DCD incorporated by 

reference in 10 CFR part 52, appendix 

D, ‘‘Design Certification Rule for the 

AP1000 Design,’’ as part of license 

amendment request (LAR) 20–001, 

‘‘Unit 3 Auxiliary Building Wall 

Seismic Gap Requirements.’’ 

For the reasons set forth in Section 3.2 

of the NRC staff’s Safety Evaluation, the 

Commission finds that: 

A. The exemption is authorized by 

law; 

B. the exemption presents no undue 

risk to public health and safety; 

C. the exemption is consistent with 

the common defense and security; 

D. special circumstances are present 

in that the application of the rule in this 

circumstance is not necessary to serve 

the underlying purpose of the rule; 

E. the special circumstances outweigh 

any decrease in safety that may result 

from the reduction in standardization 

caused by the exemption; and 

F. the exemption will not result in a 

significant decrease in the level of safety 

otherwise provided by the design. 

2. Accordingly, SNC is granted an 

exemption from the certified DCD Tier 

1 information, with corresponding 

changes to Appendix C of the facility 

Combined License, as described in the 

licensee’s request dated February 7, 

2020. This exemption is related to, and 

necessary for, the granting of License 

Amendment No. 182, which is being 

issued concurrently with this 

exemption. 

3. As explained in Section 6.0 of the 

NRC staff’s Safety Evaluation, this 

exemption meets the eligibility criteria 

for categorical exclusion set forth in 10 

CFR 51.22(c)(9). Therefore, pursuant to 

10 CFR 51.22(b), no environmental 

impact statement or environmental 

assessment needs to be prepared in 

connection with the issuance of the 

exemption. 

4. This exemption is effective as of the 

date of its issuance. 

III. License Amendment Request 

By letter dated February 7, 2020, SNC 

requested that the NRC amend COL 

NPF–91 for VEGP Unit 3. The proposed 

amendment is described in Section I of 

this Federal Register notice. 

The Commission has determined for 

this amendment that the application 

complies with the standards and 

requirements of the Atomic Energy Act 

of 1954, as amended (the Act), and the 

Commission’s rules and regulations. 

The Commission has made the findings 

required by the Act and the 

Commission’s rules and regulations in 

10 CFR chapter I, which are set forth in 

the license amendment. 

A notice of consideration of issuance 

of amendment to the COL, proposed no 

significant hazards consideration 

determination, and opportunity for a 

hearing in connection with this action, 

was published in the Federal Register 

on March 10, 2020 (85 FR 13944). No 

comments were received during the 30- 

day comment period. 

The Commission has determined that 

this amendment satisfies the criteria for 

categorical exclusion in accordance 

with 10 CFR 51.22. Therefore, pursuant 

to 10 CFR 51.22(b), no environmental 

impact statement or environmental 

assessment need be prepared for this 

amendment. 

IV. Final No Significant Hazards 

Consideration Determination 

A request for hearing was filed on 

May 11, 2020, by the Blue Ridge 

Environmental Defense League and its 

chapter, Concerned Citizens of Shell 

Bluff (collectively ‘‘BREDL’’) (ADAMS 

Package Accession No. ML20132D299). 

Under its regulations, the Commission 

may issue and make an amendment 

immediately effective, notwithstanding 

the pendency before it of a request for 

a hearing from any person, in advance 

of the holding and completion of any 

required hearing, where it has made a 

final determination that no significant 

hazards consideration is involved. 

While the hearing request was pending 

before an Atomic Safety and Licensing 

Board (ASLB), the NRC staff issued the 

amendment on August 4, 2020, after 

making a final determination that no 

significant hazards consideration was 

involved, as discussed in Section 4.0 of 

the combined safety evaluation. 

Subsequently, the ASLB denied 

BREDL’s request for hearing and 

terminated the proceeding in its order 

LBP–20–08, dated August 10, 2020 

(ADAMS Accession No. ML20223A385). 

On September 4, 2020, BREDL appealed 

the ASLB decision (ADAMS Accession 

No. ML20248J166). On December 22, 

2020, the Commission affirmed the 

ASLB’s decision (ADAMS Accession 

No. ML20357A101). 

V. Conclusion 

For the reasons set forth in the 

combined safety evaluation, the staff 

granted the exemption and issued the 

amendment that SNC requested on 

February 7, 2020. The exemption and 

amendment were issued on August 4, 

2020, as part of a combined package to 

SNC (ADAMS Package Accession No. 

ML20132A032). 

Dated: January 7, 2021. 

For the Nuclear Regulatory Commission. 

Omar R. Lopez-Santiago, 

Chief, Vogtle Project Office, Office of Nuclear 

Reactor Regulation. 

[FR Doc. 2021–00410 Filed 1–11–21; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2020–0221] 

Information Collection: NRC Form 483, 

‘‘Registration Certificate—In Vitro 

Testing with Byproduct Material Under 

General License’’ 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Notice of submission to the 

Office of Management and Budget; 

request for comment. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) has recently 

submitted a request for renewal of an 

existing collection of information to the 

Office of Management and Budget 

(OMB) for review. The information 

collection is entitled, NRC Form 483, 

‘‘Registration Certificate—In Vitro 

Testing with Byproduct Material Under 

General License.’’ 

DATES: Submit comments by February 

11, 2021. Comments received after this 

date will be considered if it is practical 

to do so, but the Commission is able to 

ensure consideration only for comments 

received on or before this date. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to https://www.reginfo.gov/ 

public/do/PRAMain. Find this 

particular information collection by 

selecting ‘‘Currently under Review— 

Open for Public Comments’’ or by using 

the search function. 

FOR FURTHER INFORMATION CONTACT: 

David Cullison, NRC Clearance Officer, 

U.S. Nuclear Regulatory Commission, 

Washington, DC 20555–0001; telephone: 

301–415–2084; email: 

Infocollects.Resource@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and 

Submitting Comments 

A. Obtaining Information 

Please refer to Docket ID NRC–2020– 

0221 when contacting the NRC about 

the availability of information for this 

action. You may obtain publicly 

available information related to this 

action by any of the following methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 


khammond on DSKJM1Z7X2PROD with NOTICES
2466 Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices 

for Docket ID NRC–2020–0221. A copy 

of the collection of information and 

related instructions may be obtained 

without charge by accessing Docket ID 

NRC–2020–0221 on this website. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to pdr.resource@

nrc.gov. A copy of the collection of 

information and related instructions 

may be obtained without charge by 

accessing ADAMS Accession No. 

ML20205L413. The supporting 

statement is available in ADAMS under 

Accession No. ML20335A465. 

• Attention: The PDR, where you may 

examine and order copies of public 

documents is currently closed. You may 

submit your request to the PDR via 

email at pdr.resource@nrc.gov or call 1– 

800–397–4209 or 301–415–4737, 

between 8:00 a.m. and 4:00 p.m. (EST), 

Monday through Friday, except Federal 

holidays. 

• NRC’s Clearance Officer: A copy of 

the collection of information and related 

instructions may be obtained without 

charge by contacting the NRC’s 

Clearance Officer, David Cullison, 

Office of the Chief Information Officer, 

U.S. Nuclear Regulatory Commission, 

Washington, DC 20555–0001; telephone: 

301–415–2084; email: 

Infocollects.Resource@nrc.gov. 

B. Submitting Comments 

The NRC encourages electronic 

comment submission through the 

Federal Rulemaking website (https://

www.regulations.gov). Please include 

Docket ID NRC–2020–0221 in your 

comment submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC will post all comment 

submissions at https://

www.regulations.gov as well as enter the 

comment submissions into ADAMS. 

The NRC does not routinely edit 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the OMB, then you 

should inform those persons not to 

include identifying or contact 

information that they do not want to be 

publicly disclosed in their comment 

submission. Your request should state 

that comment submissions are not 

routinely edited to remove such 

information before making the comment 

submissions available to the public or 

entering the comment into ADAMS. 

II. Background 

Under the provisions of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. Chapter 35), the NRC recently 

submitted a request for renewal of an 

existing collection of information to 

OMB for review entitled, NRC Form 

483, ‘‘Registration Certificate—In Vitro 

Testing with Byproduct Material Under 

General License.’’ The NRC hereby 

informs potential respondents that an 

agency may not conduct or sponsor, and 

that a person is not required to respond 

to, a collection of information unless it 

displays a currently valid OMB control 

number. 

The NRC published a Federal 

Register notice with a 60-day comment 

period on this information collection on 

October 8, 2020 (85 FR 63591). 

1. The title of the information 

collection: NRC Form 483, ‘‘Registration 

Certificate—In Vitro Testing with 

Byproduct Material Under General 

License.’’ 

2. OMB approval number: 3150–0038. 

3. Type of submission: Extension. 

4. The form number if applicable: 

NRC Form 483. 

5. How often the collection is required 

or requested: There is a one-time 

submittal of information to receive a 

validated copy of the NRC Form 483 

with an assigned registration number. In 

addition, any changes in the 

information reported on the NRC Form 

483 must be reported in writing to the 

NRC within 30 days after the effective 

date of the change. 

6. Who will be required or asked to 

respond: Any physician, veterinarian in 

the practice of veterinary medicine, 

clinical laboratory, or hospital which 

desires a general license to receive, 

acquire, possess, transfer, or use 

specified units of byproduct material in 

certain in vitro clinical or laboratory 

tests. 

7. The estimated number of annual 

responses: 6 responses. 

8. The estimated number of annual 

respondents: 6 respondents. 

9. An estimate of the total number of 

hours needed annually to comply with 

the information collection requirement 

or request: 1.12 hours. 

10. Abstract: Section 31.11 of title 10 

of the Code of Federal Regulations (10 

CFR), established a general license 

authorizing any physician, clinical 

laboratory, veterinarian in the practice 

of veterinary medicine, or hospital to 

possess certain small quantities of 

byproduct material for in vitro clinical 

or laboratory tests not involving the 

internal or external administration of 

the byproduct material or the radiation 

therefrom to human beings or animals. 

Possession of byproduct material under 

10 CFR 31.11 is not authorized until the 

physician, clinical laboratory, 

veterinarian in the practice of veterinary 

medicine, or hospital has filed the NRC 

Form 483 and received from the 

Commission a validated copy of the 

NRC Form 483 with a registration 

number. The licensee can use the 

validated copy of the NRC Form 483 to 

obtain byproduct material from a 

specifically licensed supplier. The NRC 

incorporates this information into a 

database which is used to verify that a 

general licensee is authorized to receive 

the byproduct material. 

Dated: January 6, 2021. 

For the Nuclear Regulatory Commission. 

David C. Cullison, 

NRC Clearance Officer, Office of the Chief 

Information Officer. 

[FR Doc. 2021–00331 Filed 1–11–21; 8:45 am] 

BILLING CODE 7590–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Investment Company Act Release No. 

34165; File No. 812–15066] 

Symmetry Panoramic Trust and 

Symmetry Partners, LLC 

January 6, 2021. 

AGENCY: Securities and Exchange 

Commission (‘‘Commission’’). 

ACTION: Notice. 

Notice of an application for an order 

pursuant to: (a) Section 6(c) of the 

Investment Company Act of 1940 

(‘‘Act’’) granting an exemption from 

sections 18(f) and 21(b) of the Act; (b) 

section 12(d)(1)(J) of the Act granting an 

exemption from section 12(d)(1) of the 

Act; (c) sections 6(c) and 17(b) of the 

Act granting an exemption from sections 

17(a)(1), 17(a)(2) and 17(a)(3) of the Act; 

and (d) section 17(d) of the Act and rule 

17d–1 under the Act to permit certain 

joint arrangements and transactions. 

Applicants request an order that would 

permit certain registered management 

investment companies to participate in 

a joint lending and borrowing facility. 

Applicants: Symmetry Panoramic 

Trust, a Delaware statutory trust 

registered under the Act as an open-end 

management investment company with 

multiple series, and Symmetry Partners, 

LLC (‘‘Symmetry Partners’’), a 

Connecticut limited liability company 


khammond on DSKJM1Z7X2PROD with NOTICES